OHSU and Lifecom CHAMP Project

This pilot trial in 70 patients resulted in the successful demonstration of key technical milestones necessary for success in the primary multi-centered CHAMP re-engineering research program. The medical assistant was able to use the study software tool with minimal instruction (1 hr) and within reasonable time frames (mean 21 min.). The resultant assessments showed very strong concordance with MD evaluations and end diagnoses done on the same patients (Df/Dx: 91% match, 8% overlap, 1% Dx missing from system database). Preliminary testing of the ability of the software to recognize dangerous presentations was successful (100%). A subset of patients was identified who likely could be managed by non-physician providers (24%). These findings support continued research.

View a Summary of the CHAMP Clinical Trial (pdf)

The CHAMP project involves prospective research into healthcare re-engineering. Study parameters include:		Pilot Trial results: Medical Assistant (MA) History Taking, using Medical Recording and Diagnosis Software

Efficiency, safety and efficacy Clinical diagnostic accuracy of the decision-analysis software Appropriate identification of provider handoff points Satisfaction of the patient and provider Total contact hours Cost to diagnosis ratios Standardized / reproducible care delivery models Accurate provider / cost structure Accurate cost of care estimates Portable technology utilization and reliability Standardized data collection		This pilot trial in 70 patients resulted in the successful demonstration of key technical milestones necessary for success in the primary multi-centered CHAMP re-engineering research program. The medical assistant was able to use the study software tool with minimal instruction (1 hr) and within reasonable time frames (mean 21 min.). The resultant assessments showed very strong concordance with MD evaluations and end diagnoses done on the same patients (Df/Dx: 91% match, 8% overlap, 1% Dx missing from system database). Preliminary testing of the ability of the software to recognize dangerous presentations was successful (100%). A subset of patients was identified who likely could be managed by non-physician providers (24%). These findings support continued research. View a Summary of the CHAMP Clinical Trial (pdf)